BARR PHARMACEUTICALS INC 4
4 · BARR PHARMACEUTICALS INC · Filed Dec 29, 2008
Insider Transaction Report
Form 4
FRANKOVIC RICHARD
Director
Transactions
- Exercise/Conversion
Non-Qualified Stock Options
2008-12-23−10,000→ 0 totalExercise: $57.35From: 2006-11-03Exp: 2015-11-03→ Common Stock (10,000 underlying) - Exercise/Conversion
Non-Qualified Stock Options
2008-12-23−11,250→ 0 totalExercise: $49.02From: 2004-10-23Exp: 2013-10-23→ Common Stock (11,250 underlying) - Disposition to Issuer
Common Stock
2008-12-23−2,089→ 0 total - Exercise/Conversion
Non-Qualified Stock Options
2008-12-23−7,500→ 0 totalExercise: $37.87From: 2005-10-28Exp: 2014-10-28→ Common Stock (7,500 underlying) - Exercise/Conversion
Non-Qualified Stock Options
2008-12-23−5,000→ 0 totalExercise: $54.25From: 2008-05-17Exp: 2017-05-17→ Common Stock (5,000 underlying)
Footnotes (7)
- [F1]Disposed of pursuant to a merger agreement between Issuer and Teva Pharmaceutical Industries Ltd. in exchange for 1,310 shares of Teva Common Stock having a market value of $41.82 per share on the effective date of the merger and cash in the amount of $83,351.10.
- [F2]These options were assumed by Teva Pharmaceutical Industries Ltd. ("Teva")pursuant to a merger agreement between the issuer and Teva and replaced with options to purchase 17,789 shares of Common Stock of Teva for an exercise price of $31.00.
- [F3]These options were assumed by Teva Pharmaceutical Industries Ltd. ("Teva")pursuant to a merger agreement between the issuer and Teva and replaced with options to purchase 11,859 shares of Common Stock of Teva for an exercise price of $23.59.
- [F4]These options were assumed by Teva Pharmaceutical Industries Ltd. ("Teva")pursuant to a merger agreement between the issuer and Teva and replaced with options to purchase 15,812 shares of Common Stock of Teva for an exercise price of $36.27.
- [F5]These options were assumed by Teva Pharmaceutical Industries Ltd. ("Teva")pursuant to a merger agreement between the issuer and Teva and replaced with options to purchase 15,812 shares of Common Stock of Teva for an exercise price of $30.89.
- [F6]These options were assumed by Tev Pharmaceutical Industries Ltd. ("Teva")pursuant to a merger agreement between the issuer and Teva and replaced with options to purchase 7,906 shares of Common Stock of Teva for an exercise price of $34.31.
- [F7]These options were assumed by Tev Pharmaceutical Industries Ltd. ("Teva")pursuant to a merger agreement between the issuer and Teva and replaced with options to purchase 15,812 shares of Common Stock of Teva for an exercise price of $25.14.